Schelker, R. C. and Huber, E. and Herr, W. and Vogelhuber, M. (2015) Marked regression of myelofibrosis during reduced-dose dasatinib treatment in chronic myelogenous leukemia in accelerated phase. Oncology Research and Treatment, 38 (Suppl5). p. 131. ISSN 2296-5270, 2296-5262
Full text not available from this repository.| Item Type: | Article |
|---|---|
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) |
| Depositing User: | Petra Gürster |
| Date Deposited: | 26 Aug 2020 06:26 |
| Last Modified: | 26 Aug 2020 06:26 |
| URI: | https://pred.uni-regensburg.de/id/eprint/4679 |
Actions (login required)
 |
View Item |
